Ganciclovir

Kathryn Dzintars, Pharm.D. BCPS, Paul A. Pham, Pharm.D., Alice Jenh Hsu, Pharm.D.
Ganciclovir is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of CMV retinitis (IV) in immunocompromised pts.
  • Prophylaxis and prevention of CMV disease recurrence in pts with AIDS and solid organ transplant recipients (use for primary prophylaxis in HIV is FDA approved but not currently recommended; valganciclovir preferred).
  • Herpes keratitis (ophthalmic gel)

NON-FDA APPROVED USES

  • Castleman’s disease (limited data)

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Treatment of CMV retinitis (IV) in immunocompromised pts.
  • Prophylaxis and prevention of CMV disease recurrence in pts with AIDS and solid organ transplant recipients (use for primary prophylaxis in HIV is FDA approved but not currently recommended; valganciclovir preferred).
  • Herpes keratitis (ophthalmic gel)

NON-FDA APPROVED USES

  • Castleman’s disease (limited data)

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: May 29, 2016